TARA
Protara Therapeutics Inc
NASDAQ: TARA · HEALTHCARE · BIOTECHNOLOGY
$5.33
+3.09% today
Updated 2026-04-30
Market cap
$273.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$3 – $8
Volume
1.0M
Protara Therapeutics Inc (TARA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $2.95M | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | -100.0% | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $57000.00 | $27000.00 | — | $57000.00 | $123000.00 | $148000.00 | $115000.00 | $16000.00 | $196000.00 | $1.17M | $247000.00 | $341000.00 | $332000.00 | $362000.00 |
| Gross profit | $-57000.00 | $-27000.00 | $2.95M | $-57000.00 | $-123000.00 | $-148000.00 | $-115000.00 | $-16000.00 | $-196000.00 | $-1.17M | $-247000.00 | $-341000.00 | $-332000.00 | $-362000.00 |
| Gross margin | — | — | 100.0% | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $5.91M | $3.99M | $6.43M | $12.38M | $18.87M | $21.69M | $15.51M | $6.44M | $11.88M | $21.09M | $16.81M | $24.79M | $31.70M | $42.63M |
| SG&A | — | — | $4.10M | $8.49M | $9.84M | $105989.00 | $10.57M | $8.82M | $22.46M | $26.40M | $20.74M | $18.62M | $17.45M | $21.92M |
| Operating income | $-8.00M | $-7.12M | $-7.58M | $-20.87M | $-28.70M | $-30.36M | $-26.08M | $-15.25M | $-34.44M | $-47.49M | $-67.06M | $-43.61M | $-49.15M | $-64.55M |
| Operating margin | — | — | -257.1% | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-7.91M | $-7.02M | $-2.46M | $-21.32M | $-28.40M | $-29.82M | $-20.61M | $-7.81M | $-33.78M | $-45.40M | $-64.57M | $-43.27M | $-48.82M | $-64.19M |
| EBITDA margin | — | — | -83.3% | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-7.97M | $-7.05M | $-2.48M | $-21.38M | $-28.53M | $-29.96M | $-20.73M | $-7.83M | $-33.98M | $-45.52M | $-64.81M | $-43.61M | $-49.15M | $-64.55M |
| Interest expense | — | $861000.00 | $857000.00 | $144000.00 | $193000.00 | $259000.00 | $0.00 | $0.00 | $34000.00 | $1.74M | $1.14M | — | $4.17M | — |
| Income tax | — | — | $5.09M | $-363000.00 | $372000.00 | $657000.00 | $5.35M | $-262000.00 | $-466000.00 | $-117000.00 | $-1.14M | $-341000.00 | — | — |
| Effective tax rate | 0.0% | 0.0% | 290.6% | 1.7% | -1.3% | -2.2% | -26.6% | 1.7% | 1.4% | 0.2% | 1.7% | 0.8% | 0.0% | 0.0% |
| Net income | $-7.97M | $-7.91M | $-3.34M | $-21.38M | $-28.53M | $-29.96M | $-25.44M | $-14.99M | $-33.98M | $-47.25M | $-65.95M | $-40.42M | $-44.60M | $-57.44M |
| Net income growth (YoY) | — | +0.7% | +57.8% | -539.6% | -33.4% | -5.0% | +15.1% | +41.1% | -126.6% | -39.1% | -39.6% | +38.7% | -10.3% | -28.8% |
| Profit margin | — | — | -113.4% | — | — | — | — | — | — | — | — | — | — | — |